Bispecifics is a new type of cancer treatment that helps the immune system fight cancer.
It works by connecting cancer cells with immune cells, such as white blood cells. This helps the immune system recognize and destroy cancer cells more effectively.
By bringing these cells together, bispecific antibody therapy helps the body target and attack cancer.
Our partnership with Ascension St. Vincent’s Riverside allows us to provide this treatment in an outpatient setting while maintaining access to a trusted hospital partner if additional care is needed.
This partnership is an important step toward making advanced cancer treatment more accessible and convenient for our patients.
We’re proud to offer the latest in cancer-fighting technology while helping patients spend less time in the hospital and more time at home with their families.
*CSNF currently offers bispecifics for the following cancers: multiple myeloma; diffuse large b-cell lymphoma; extensive stage-small cell lunch cancer.
